NanoViricides to Present at the Pharma Partnering Summit 2025 in Boston Today, November 14th - NV-387 is Effective Against H3N2

Core Viewpoint - NanoViricides, Inc. is a clinical stage company focused on developing broad-spectrum antiviral drugs that are designed to be effective against viruses without the risk of escape [1] Group 1: Event Information - NanoViricides will present at the Pharma Partnering Summit 2025 on November 14, 2025, from 11:25 am to 11:45 am ET [1] - The event will take place at the Hilton Boston Logan Airport in Boston, MA [1]